| Specimen requirement | Spot urine Volume: 10 mL (* Do not discard the acid preservatives inside the bottle!) |
||||||||||
| Authorisation code required | No | ||||||||||
| 24 Hr available service | No | ||||||||||
| Precaution | Guideline for Specimen Collection
|
||||||||||
| Method | Liquid chromatography-tandem mass spectrometry |
||||||||||
| Reference interval |
For patients > 12 years who have a history of neuroblastoma and are currently in remission, the observed spot VMA/Cr ratio is < 3 µmol/mmol Cr based on local laboratory data. (Source: |
||||||||||
| Clinical indication | Diagnosis of catecholamine-secreting neurochromaffin tumours (i.e. pheochromocytomas, paragangliomas, or neuroblastomas) | ||||||||||
| Result interpretation |
Increased urine excretion is found in phaeochromocytomas, neuroblastoma and related tumors. See also urine catecholamines, urine free metanephrines. |
||||||||||
| Measurement of uncertainty | See table. | ||||||||||
| Frequency of measurement | Biweekly |